Consolidated Statements of Operations and Comprehensive Income (Loss) | ||||||||
(Unaudited) | ||||||||
For the six months ended December 31, | ||||||||
2022 |
2023
| |||||||
RMB | RMB | US$ | ||||||
Net revenues | 603,030,131 | 26,066,660 | 3,680,328 | |||||
Cost of revenues | 549,236,760 | 66,617,485 | 9,405,662 | |||||
Gross profit (loss) | 53,793,371 | (40,550,825 | ) | (5,725,334 | ) | |||
Operating expenses: | ||||||||
Selling and marketing expenses | 14,266,412 | 5,830,986 | 823,272 | |||||
General and administrative expenses | 36,311,852 | 22,360,766 | 3,157,096 | |||||
Research and development expenses | 90,159,028 | 55,648,133 | 7,856,910 | |||||
Total operating expenses | 140,737,292 | 83,839,885 | 11,837,278 | |||||
Loss from operations | (86,943,921 | ) | (124,390,710 | ) | (17,562,612 | ) | ||
Other expenses (income): | ||||||||
Finance income | (3,771,346 | ) | (680,536 | ) | (96,084 | ) | ||
Interest income | (144,938 | ) | (153,112 | ) | (21,618 | ) | ||
Other income | (2,752,999 | ) | (3,507,095 | ) | (495,164 | ) | ||
Total other income | (6,669,283 | ) | (4,340,743 | ) | (612,866 | ) | ||
Loss before income tax provision | (80,274,638 | ) | (120,049,967 | ) | (16,949,746 | ) | ||
Income tax provision | - | (17,394 | ) | (2,456 | ) | |||
Net loss | (80,274,638 | ) | (120,032,573 | ) | (16,947,290 | ) | ||
Less: net loss attributable to noncontrolling interests | - | (1,528,282 | ) | (215,777 | ) | |||
Net loss attributable to Nano Labs Ltd | (80,274,638 | ) | (118,504,291 | ) | (16,731,513 | ) | ||
Comprehensive income (loss): | ||||||||
Net loss | (80,274,638 | ) | (120,032,573 | ) | (16,947,290 | ) | ||
Other comprehensive income (loss): | ||||||||
Foreign currency translation adjustment | 3,229,764 | (1,616,096 | ) | (228,175 | ) | |||
Comprehensive Loss | (77,044,874 | ) | (121,648,669 | ) | (17,175,465 | ) | ||
Comprehensive loss attributable to noncontrolling interests | - | (1,528,352 | ) | (215,787 | ) | |||
Comprehensive loss attributable to Nano Labs Ltd | (77,044,874 | ) | (120,120,317 | ) | (16,959,678 | ) | ||
Net loss per ordinary share attributable to Nano Labs Ltd | ||||||||
Basic* | (1.47 | ) | (1.91 | ) | (0.27 | ) | ||
Diluted* | (1.47 | ) | (1.91 | ) | (0.27 | ) | ||
Weighted average number of shares used in per share calculation: | ||||||||
Basic* | 54,571,995 | 61,970,664 | 61,970,664 | |||||
Diluted* | 54,571,995 | 61,970,664 | 61,970,664 |
Nano Labs Announces Second Half of 2023 Financial Results
| | More MCAD News |
|
*Giving effect of the 2-for-1 reverse stock split effective on January 31, 2024.
RELATED NEWS